Image via Getty/Noah Graham
NBA spokesman Mike Bass has addressed the league’s decision to not test players for marijuana in the upcoming season, The New York Times‘ Marc Stein reports.
“Due to the unusual circumstances in conjunction with the pandemic, we have agreed with the NBPA to suspend random testing for marijuana for the 2020-21 season and focus our random testing program on performance-enhancing products and drugs of abuse,” Bass said.
See original story below.
The NBA will reportedly forego testing its players for marijuana for the 2020-21 campaign, continuing a revision to league policy that started during the season restart in Orlando just a few months ago, according to Ben Dowsett.
The belief is that the NBA wants to limit the amount of unnecessary contacts with players, who must already navigate the extensive protocols that come with trying to complete a shortened season in the midst of the COVID-19 pandemic. Prior to play in the bubble, it was announced that testing for recreational drugs would be suspended. Now that the league has chosen to do without marijuana testing again, it could mean that the NBA is trending towards phasing out the program.
Founder & Interim Editor of L.A. Cannabis News